A pair of scientific papers has identified the same single gene as the source of red colouring in birds. The gene makes an enzyme that lets the birds convert yellow pigments, which they eat, into red ...

ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Encouraging Early Data for Obesity Programs On January 6, 2026, ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Confirmed news of Eli Lilly and Co. purchasing Ventyx Biosciences Inc. for $14 per share arrived within a day of swirling rumors that drove shares of the San Diego-based biopharma company up by more ...

Gain Therapeutics (GANX) provided additional biomarker and clinical data from the Phase 1b clinical study of GT-02287 in people with Parkinson’s ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...

A rare genetic variant found in families affected by schizophrenia completely abolishes the function of TAAR1, an emerging ...

Investors will start the first full week of 2026 watching to see if the market can post positive returns for the "Santa Claus ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing or slowing the disease, rather than reversing it.  Using different mouse ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, "The Gain-of-Function ...